舒张性心力衰竭早期防治专家建议  

Expert advice on early prevention and treatment of diastolic heart failure

作　　者：无 廖玉华[2] 

机构地区：[1]中国心衰中心联盟 [2]华中科技大学同济医学院附属协和医院心内科,武汉430022

出　　处：《临床心血管病杂志》2021年第1期1-6,共6页Journal of Clinical Cardiology

摘　　要：舒张性心力衰竭(DHF)已经成为一个公共健康问题,其发病主要涉及心血管代谢危险因素(CMRF)人群。对于DHF早期诊断,本专家组建议推荐超声心动图测量左室舒张功能指标和检测利钠肽水平;在治疗高血压、高脂血症、2型糖尿病(T2D)及肥胖等CMRF时,推荐应用SGLT2抑制剂、二甲双胍、GLP-1受体激动剂和他汀等药物进行心外膜脂肪组织(EAT)聚集的早期干预,预防DHF。Diastolic heart failure(DHF)has become a major public health problem.DHF mainly involves the cardiovascular metabolic risk factors(CMRF)population.Our expert advice recommends to measure left ventricular diastolic function by echocardiography and to detect the level of natriuretic peptide for early diagnosis of DHF.In addition to the treatment of CMRF such as hypertension,high LDL-C,type 2 diabetes and obesity,using ths SGLT2 inhibitors,metformin,GLP-1 receptor agonists or statins early intervention of epicardial adipose tissue(EAT)aggregation is recommended to prevent DHF.

关 键 词：舒张性心力衰竭 心血管代谢危险因素 心外膜脂肪组织 早期预防 

分 类 号：R541.6[医药卫生—心血管疾病]